incontinence

(redirected from Urge Urinary Incontinence)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms.
Related to Urge Urinary Incontinence: stress urinary incontinence

incontinence

[in′känt·ən·əns]
(medicine)
Inability to control the natural evacuations, as the feces or the urine; specifically, involuntary evacuation from organic causes.
References in periodicals archive ?
VESIcare is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and urinary frequency.
That finding amplifies the association between urinary incontinence and postpartum depression because studies have shown women who have a C-section are less likely to develop urge urinary incontinence than are those who deliver vaginally, Dr.
MYRBETRIQ (TM)(mirabegron) is a prescription medicine for adults used to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
OAB is a medical condition whose symptoms include urinary frequency, urgency, and urge urinary incontinence, the accidental loss of urine that occurs after the strong, sudden urge to urinate.
Currently, the therapeutic treatment options available in the market are basically to treat urge urinary incontinence (UUI) and are associated with certain side effects that nullify the effect of the drug (such as the incidence of dry mouth).
Alza Pharmaceuticals markets Ditropan XL for the treatment of urge urinary incontinence.
VESIcare tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Drug therapy for urinary disorders has predominantly focused on the overactive bladder market - particularly urge urinary incontinence (UUI).
s Sanctura XR product, which is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency.
Both trials in the Phase III clinical program were randomized, double-blind, placebo-controlled trials comparing the reduction in the frequency of urination and the reduction in urge urinary incontinence episodes among drug-treated patients versus placebo patients.
Vesicare(R) (Solifenacin Succinate) is a once-daily oral medication and is indicated for the treatment of overactive bladder in adults with symptoms of urinary urgency, urge urinary incontinence, and urinary frequency.
Both trials in the Phase III clinical program are randomized, double-blind, placebo-controlled trials comparing the reduction in the frequency of urination and the reduction in urge urinary incontinence episodes among drug-treated patients versus placebo patients.